Fig. 1From: Preclinical evaluation of the theranostic potential of 89Zr/177Lu-labeled anti-TROP-2 antibody in triple-negative breast cancer modelScheme of the study. Anti-TROP-2 antibody NY003 was first conjugated with DFO and DTPA and then radiolabeled with 89Zr and 177Lu for immunoPET imaging and radioimmunotherapy (RIT) studies, respectivelyBack to article page